FDA approves PMA supplement of patient registry data for the OrthoLogic 1000 bone growth stimulator.PHOENIX--(BUSINESS WIRE)--Jan. 6, 1997--OrthoLogic Corp. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :OLGC OLGC Ontario Lottery and Gaming Corporation ) announced today the FDA's approval of a PMA PMA (papillary-marginal-attached), n a system of epidemiologic scoring of periodontal disease devised by Schour and Massler in which the symbols denote the areas involved in gingival inflammation. PMA Progressive muscular atrophy supplement filed with respect to its patient registry data. Subsequent to the March 1994 approval of the OrthoLogic(R) 1000, OrthoLogic has maintained a registry of all patients using the device. In July 1996, OrthoLogic submitted to the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. a PMA supplement of non-union patient registry data. A non-union fracture is a fracture that remains unhealed for a minimum of nine months. The company reported results on the follow-up data that was received on more than 400 non-union patients who have completed their treatment. "We are very pleased to announce these registry results. This data validates the efficacy of the OrthoLogic 1000 in the healing of non-union fractures. Overall, 72.3% of the patients on which we received follow-up data healed. Additionally, these patients healed in an average of 4.9 months," stated George Oram, OrthoLogic's president and chief operating officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. . "We are confident that this data will confirm the OrthoLogic 1000 as the standard for bone growth stimulators and result in our achieving market leadership. The OrthoLogic 1000, with its 30 minutes per day treatment time, clearly has the advantage over competitive products requiring a minimum of 10 hours treatment time per day," Oram stated. OrthoLogic develops, manufactures and markets proprietary, technologically advanced orthopaedic devices designed to enhance the healing of diseased, damaged or degenerated musculoskeletal musculoskeletal /mus·cu·lo·skel·e·tal/ (-skel´e-t'l) pertaining to or comprising the skeleton and muscles. mus·cu·lo·skel·e·tal adj. Relating to or involving the muscles and the skeleton. tissue. Founded in 1987, the company is headquartered in Phoenix. -0- This release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. which are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements including, but not limited to, these regarding market leadership. Actual results could vary materially from the description contained herein due to many factors including, but no limited to, market acceptance of the OrthoLogic 1000, developments by competitors, possible technological change, government regulation and the "Risk Factors" set forth in the company's prospectus dated April 25, 1996. The forward-looking statements should be considered in light of these risks and uncertainties. CONTACT: OrthoLogic Corp., Phoenix George A. Oram or Richard R. Cartwright, 602/437-5520 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion